CMP
Coston McIsaac & Partners’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $346K | Sell |
14,299
-4,023
| -22% | -$97.3K | 0.09% | 102 |
|
|
2025
Q1 | $464K | Buy |
18,322
+2,328
| +15% | +$59K | 0.14% | 81 |
|
|
2024
Q4 | $424K | Sell |
15,994
-3,099
| -16% | -$82.2K | 0.13% | 86 |
|
|
2024
Q3 | $552 | Sell |
19,093
-443
| -2% | -$13 | 0.16% | 76 |
|
|
2024
Q2 | $546K | Buy |
19,536
+1,034
| +6% | +$28.9K | 0.17% | 70 |
|
|
2024
Q1 | $513K | Buy |
18,502
+633
| +4% | +$17.6K | 0.16% | 71 |
|
|
2023
Q4 | $514K | Buy |
17,869
+98
| +0.6% | +$2.82K | 0.18% | 70 |
|
|
2023
Q3 | $589K | Buy |
17,771
+70
| +0.4% | +$2.32K | 0.22% | 62 |
|
|
2023
Q2 | $649K | Buy |
17,701
+72
| +0.4% | +$2.64K | 0.22% | 68 |
|
|
2023
Q1 | $719K | Buy |
17,629
+635
| +4% | +$25.9K | 0.27% | 62 |
|
|
2022
Q4 | $870 | Sell |
16,994
-130
| -0.8% | -$7 | 0.34% | 58 |
|
|
2022
Q3 | $749K | Buy |
17,124
+33
| +0.2% | +$1.44K | 0.34% | 55 |
|
|
2022
Q2 | $896K | Buy |
+17,091
| New | +$896K | 0.54% | 45 |
|